O. Lyon‐Caen

5.9k total citations · 1 hit paper
99 papers, 3.9k citations indexed

About

O. Lyon‐Caen is a scholar working on Pathology and Forensic Medicine, Neurology and Molecular Biology. According to data from OpenAlex, O. Lyon‐Caen has authored 99 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pathology and Forensic Medicine, 25 papers in Neurology and 22 papers in Molecular Biology. Recurrent topics in O. Lyon‐Caen's work include Multiple Sclerosis Research Studies (29 papers), Peripheral Neuropathies and Disorders (13 papers) and Hereditary Neurological Disorders (9 papers). O. Lyon‐Caen is often cited by papers focused on Multiple Sclerosis Research Studies (29 papers), Peripheral Neuropathies and Disorders (13 papers) and Hereditary Neurological Disorders (9 papers). O. Lyon‐Caen collaborates with scholars based in France, United States and Netherlands. O. Lyon‐Caen's co-authors include Ayman Tourbah, Olivier Gout, Bertrand Fontaine, F Lhermitte, J.‐J. Hauw, R Escourolle, P Castaigne, A Buge, M T Iba-Zizen and Catherine Lubetzki and has published in prestigious journals such as Nature, The Lancet and Neurology.

In The Last Decade

O. Lyon‐Caen

95 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Paramedian thalamic and midbrain infarcts: Clinical and neuropathological study

1981 370 citations O. Lyon‐Caen et al. Annals of Neurology profile →

Peers

Countries citing papers authored by O. Lyon‐Caen

Since Specialization

Citations

This map shows the geographic impact of O. Lyon‐Caen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Lyon‐Caen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Lyon‐Caen more than expected).

Fields of papers citing papers by O. Lyon‐Caen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Lyon‐Caen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Lyon‐Caen. The network helps show where O. Lyon‐Caen may publish in the future.

Co-authorship network of co-authors of O. Lyon‐Caen

This figure shows the co-authorship network connecting the top 25 collaborators of O. Lyon‐Caen. A scholar is included among the top collaborators of O. Lyon‐Caen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Lyon‐Caen. O. Lyon‐Caen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High doses of biotin in chronic progressive multiple sclerosis: A pilot study 2015 ·Multiple Sclerosis and Related Disorders ·Frédéric Sedel, Caroline Papeix, Agnès Bellanger, Valérie Touitou, Christine Lebrun‐Frénay, Damien Galanaud, Olivier Gout, O. Lyon‐Caen, Ayman Tourbah	156
2	Guillain-Barre Syndrome, Influenzalike Illnesses, and Influenza Vaccination During Seasons With and Without Circulating A/H1N1 Viruses 2011 ·American Journal of Epidemiology ·Lamiae Grimaldi‐Bensouda, Annick Alpérovitch, Gérard Besson, Christophe Vial, Jean‐Marie Cuisset, Caroline Papeix, O. Lyon‐Caen, Jacques Bénichou, Michel Rossignol, (unknown)	54
3	Biotin-Responsive Basal Ganglia Disease in Ethnic Europeans With Novel SLC19A3 Mutations 2010 ·Archives of Neurology ·Rabab Debs, Christel Depienne, Agnès Rastetter, Agnès Bellanger, Bertrand Degos, Damien Galanaud, Boris Keren, O. Lyon‐Caen, Alexis Brice, Frédéric Sedel	73
4	Cerebrotendinous Xanthomatosis Presenting with Severe Externalized Disorder:Improvement After One Year of Treatment with Chenodeoxycholic Acid 2010 ·CNS Spectrums ·Olivier Bonnot, Matthew J. Fraidakis, (unknown), (unknown), (unknown), Monique Plaza, O. Dubourg, O. Lyon‐Caen, Frédéric Sedel, David Cohen	33
5	Rapid onset frontal leukodystrophy with decreased diffusion coefficient and neuroaxonal spheroids 2009 ·Journal of Neurology ·Élisabeth Maillart, Audrey Rousseau, Damien Galanaud, Françoise Gray, Marc Polivka, Pierre Labauge, Jean‐Jacques Hauw, O. Lyon‐Caen, Olivier Gout, Frédéric Sedel	14
6	Quantification of Neutralizing Antibodies to Human Type I Interferons Using Division-Arrested Frozen Cells Carrying an Interferon-Regulated Reporter-Gene 2008 ·Journal of Interferon & Cytokine Research ·Christophe Lallemand, Jean–François Méritet, Roger H. Erickson, Sidney E. Grossberg, E Roullet, O. Lyon‐Caen, Pierre Lebon, Michaël G. Tovey	36
7	Intravenous immunoglobulins-induced eczematous eruption: A long-term follow-up study 2008 ·European Journal of Internal Medicine ·(unknown), Stéphane Barète, Zahir Amoura, C. Francès, O. Lyon‐Caen, Bénédicte Lebrun‐Vignes	12
8	Les maladies métaboliques héréditaires traitables en neurologie 2007 ·Revue Neurologique ·F. Sedel, O. Lyon‐Caen, Jean‐Marie Saudubray	7
9	Troubles neurologiques par carence en vitamine B12 déclenchés par le protoxyde d’azote 2007 ·Revue Neurologique ·(unknown), F. Sedel, Savine Vicart, O. Lyon‐Caen, B. Fontaine	7
10	Interferons in multiple sclerosis: Ten years' experience 2007 ·Biochimie ·Ayman Tourbah, O. Lyon‐Caen	17
11	Leucoencéphalopathies génétiques de l’adulte 2005 ·Revue Neurologique ·F. Sedel, Ayman Tourbah, Nicole Baumann, Bertrand Fontaine, Patrick Aubourg, Catherine Lubetzki, O. Lyon‐Caen	6
12	Acute demyelination: an insight into the effect of mitoxantrone on CNS lesions 2005 ·Journal of Neuroradiology ·Ayman Tourbah, J.L. Stievenart, Gilles Edan, (unknown), Didier Dormont, O. Lyon‐Caen	3
13	Neuropathie optique inflammatoire aiguë : facteurs pronostiques cliniques et IRM 2002 ·Revue Neurologique ·Romain Deschamps, Olivier Gout, Bertrand Fontaine, (unknown), E. A. Cabanis, O. Lyon‐Caen, Ayman Tourbah	3
14	[The first episode of central nervous system demyelinization and hepatitis B virus vaccination]. 2000 ·PubMed ·Emmanuel Touzé, Olivier Gout, M H Verdier-Taillefer, O. Lyon‐Caen, Annick Alpérovitch	41
15	Gliotoxicity, reverse transcriptase activity and retroviral RNA in monocyte/macrophage culture supernatants from patients with multiple sclerosis 1997 ·FEBS Letters ·Armelle Ménard, Rim Amouri, (unknown), (unknown), Arthur Brouillet, (unknown), Christian Gény, Lionel Deforges, (unknown), (unknown), O. Lyon‐Caen, Bernard Mandrand, Tomáš Dobránsky, François Rieger, Hervé Perron	35
16	Exclusion of the candidate locus FSP1 in six families with late-onset autosomal dominant spastic paraplegia 1995 ·Neuromuscular Disorders ·Bertrand Fontaine, (unknown), Jamïlé Hazan, Alexandra Dürr, Giovanni Stévanin, Christiane Penet, J Reboul, (unknown), O. Lyon‐Caen, Nicole Baumann, Jean Weissenbach, Alexis Brice	5
17	Clinical spectrum of CADASIL: a study of 7 families 1995 ·The Lancet ·Hugues Chabriat, Katayoun Vahedi, M G Bousser, M T Iba-Zizen, Anne Joutel, A Nibbio, Tamás Nagy, Elisabeth Tournier‐Lasserve, Marie‐Odile Krebs, Jean‐Philippe Julien, Xavier Ducrocq, M Levasseur, J.‐L. Mas, Bruno Dubois, Pascale Homeyer, O. Lyon‐Caen	466
18	Frequency and relevance of IgM intrathecal synthesis in multiple sclerosis 1995 ·European Journal of Neurology ·J Reboul, P. Lambin, Annie Gervais, O Gaillard, J Delattre, François Bricaire, O. Lyon‐Caen, E Schuller	2
19	Analysis of retroviral sequences in the spinal form of multiple sclerosis 1991 ·Annals of Neurology ·Flore Rozenberg, (unknown), Catherine Lubetzki, Pierre Lebon, O. Lyon‐Caen, Michel Brahic, Jean‐François Bureau	9
20	[Expression of interleukin 2 receptor and class II histocompatibility antigens on lymphocytes of the cerebrospinal fluid in patients with multiple sclerosis and other neurological diseases]. 1987 ·PubMed ·Elisabeth Tournier‐Lasserve, O. Lyon‐Caen, E Roullet, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact